Soluble Endoglin for the Prediction of Preeclampsia in a High Risk Cohort

Publication/Presentation Date

1-2010

Abstract

OBJECTIVES: To evaluate soluble endoglin (sEng) and the soluble fms-like tyrosine kinase 1 (sFlt1) to placental growth factor (PlGF) ratio for the prediction of preeclampsia in high-risk women, and to evaluate differences in sEng between women with high-risk singleton and multiple gestation pregnancies.

STUDY DESIGN: We collected serial serum specimens from 119 women at high preeclampsia risk. sEng, sFlt1 and PlGF were measured by ELISA.

RESULTS: Among subjects who did not develop preeclampsia, mean serum sEng was significantly higher in those with multiple gestation pregnancies vs. high-risk singletons. Among women with singleton gestations, mean serum sEng was higher in subjects who developed early-onset (<34 >weeks) and late-onset (>or= 34 weeks) preeclampsia, as compared with subjects without preeclampsia, from 22 weeks and 28 weeks gestation onward, respectively. The within-woman rate of change of sEng was also higher in women who later developed preeclampsia.

CONCLUSIONS: sEng is higher in women with multiple gestations vs. high-risk singleton pregnancies. In high-risk women, serum sEng is increased prior to preeclampsia onset.

Volume

29

Issue

3

First Page

330

Last Page

341

ISSN

1525-6065

Disciplines

Hematology | Medical Sciences | Medical Specialties | Medicine and Health Sciences | Obstetrics and Gynecology

PubMedID

20670156

Department(s)

Department of Medicine, Department of Medicine Faculty

Document Type

Article

Link to Full Text

Share

COinS